Electronic Compliance Monitoring in Opioid Substitution Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Opiate Dependence
- Sponsor
- Kuopio University Hospital
- Enrollment
- 37
- Locations
- 1
- Primary Endpoint
- The effectiveness of treatment (Treatment Outcomes Profile TOP)
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
The purpose of this study is to improve unsupervised dosing of opioid substitution medications. The aim of the study is to examine whether electronic compliance monitoring provides some advantages to patients'treatment and what kind of patients especially benefit from monitoring. We would also like to know if electronic compliance monitoring can prevent the abuse/diversion of medications and how implementing this method to wider treatment facilities succeeds.
Investigators
Eligibility Criteria
Inclusion Criteria
- •opiate dependence F11.22 according to ICD-10
- •Suboxone treatment
- •the duration of substitution treatment before study at least one month
- •stable medication dose
Exclusion Criteria
- •unstable situation in life according to treatment staff's opinions
Outcomes
Primary Outcomes
The effectiveness of treatment (Treatment Outcomes Profile TOP)
Time Frame: Every two months.
Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment.
Secondary Outcomes
- Patients´opinions about the treatment.(Once when the study phase ends (after four months).)